Ligand Pharmaceuticals
LGND
#3340
Rank
S$5.35 B
Marketcap
S$268.73
Share price
-0.70%
Change (1 day)
90.09%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): S$80.67 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.25 Billion. In 2024 the company made an earning of S$7.11 Million a decrease over its 2023 earnings that were of S$82.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$80.67 M1033.13%
2024 S$7.11 M-91.37%
2023 S$82.49 M-7.59%
2022 S$89.26 M4%
2021 S$85.83 M296.42%
2020 S$21.65 M-97.97%
2019 S$1.06 B275.62%
2018 S$0.28 B237.48%
2017 S$84.21 M49.05%
2016 S$56.5 M55.41%
2015 S$36.35 M36.87%
2014 S$26.56 M29.59%
2013 S$20.49 M1309.35%
2012 S$1.45 M-43.97%
2011 S$2.59 M-113.19%
2010 -S$19.69 Million59.86%
2009 -S$12.32 Million-61.33%
2008 -S$31.84 Million-58.75%
2007 -S$77.18 Million20.52%
2006 -S$64.04 Million81.27%
2005 -S$35.33 Million
2003 -S$24.6 Million-20.6%
2002 -S$30.98 Million4.38%
2001 -S$29.68 Million-48.83%
2000 -S$58 Million-19.74%
1999 -S$72.26 Million-19.06%
1998 -S$89.27 Million126.71%
1997 -S$39.38 Million-5.83%
1996 -S$41.82 Million136.23%
1995 -S$17.7 Million-33.97%
1994 -S$26.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.55 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.20 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.86 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.57 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.35 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.61 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.30 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.95 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$79.37 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA